*Hiroshi Ueno1, Sachiko Mori2, Eriko Kitano2, Yu Takahashi2, Takeshi Ishihara2 (1. KawasakiUniversity of Medical Welfare, 2. Kawasaki Medical School)
Session information
Poster
F. Basic and Clinical Science of Mental Disorders
[3P] 63 Depressive and Bipolar disorders
Fri. Jul 26, 2024 12:50 PM - 1:50 PM Poster Room (Marine Messe Fukuoka Hall B)
*Rei Yokoyama1,2, Yukio Ago2, Hisato Igarashi1, Momoko Higuchi1, Masato Tanuma1, Yuto Shimazaki1, Kaoru Seiriki1, Misuzu Hayashida1, Shun Yamaguchi3,4, Hirokazu Tanaka5, Takanobu Nakazawa6, Kenji Hashimoto7, Atsushi Kasai1,8, Hitoshi Hashimoto1,9,10,11,12 (1. Lab. Mol. Neuropharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ., Osaka, Japan, 2. Dept. Cell. Mol. Pharmacol., Grad. Sch. Biomed. Health Sci., Hiroshima Univ., Hiroshima, Japan, 3. Dept. Morph. Neurosci., Grad. Sch. Med., Gifu Univ., Gifu, Japan, 4. Ctr. One Med. Innov. Transl. Res., Inst. Adv. Study, Gifu Univ., Gifu, Japan, 5. Fac. Info. Technol., Tokyo City Univ., Tokyo, Japan, 6. Dept. Biosci., Tokyo Univ. Agri., Tokyo, Japan, 7. Div. Clin. Neurosci., Chiba Univ. Ctr. Forensic. Mental Hlth., Chiba, Japan, 8. Sys. Brain Sci. Project, Drug Innov. Ctr., Grad. Sch. Pharmaceut. Sci., Osaka Univ., Osaka, Japan, 9. Mol. Res. Ctr. Children’s Mental Dev., United Grad. Sch. Child Dev., Osaka Univ., Osaka, Japan, 10. Inst. Datability Sci., Osaka Univ., Osaka, Japan, 11. Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., Osaka, Japan, 12. Dep. Mol. Pharmaceut. Sci., Grad. Sch. Med., Osaka Univ., Osaka, Japan)
*Gakuya Takamatsu1, Yoko Manome4, Kaoru Kinjo1, Kanako Toyama1,9, Yuko Akamine1, Kumiko Yanagi5, Kae Koganebuchi3,6, Dimitar Dimitrov7, JunSeok Lee1, Minami Hasegawa4, Tomoko Hayakawa8,1, Tsuyoshi Kondo2, Tomoyuki Takahashi7, Tadashi Kaname5, Hirotaka James Okano4, Ryosuke Kimura3, Masayuki Matsushita1 (1. Department of Molecular & Cellular Physiology, Graduate School of Medicine, University of the Ryukyus, 2. Dept. of Neuropsy., Grad. Sch. of Med., Univ. of the Ryukyus, Okinawa, Japan, 3. Dept. of Hum. Biol. Anat., Grad. Sch. of Med., Univ. of the Ryukyus, Okinawa, Japan, 4. Div. of Regen. Med., Jikei Univ. Sch. of Med., Tokyo, Japan, 5. Dept. of Gen. Med., Natl. Ctr. for Chd. Hlth. Dev., Tokyo, Japan, 6. Dept. of Biol. Sci., Grad. Sch. of Sci., Univ. of Tokyo, Tokyo, Japan, 7. Cel. Mol. Syn. Func. Unit, Okinawa Inst. of Sci. Tech. Grad. Univ., Okinawa, Japan, 8. Dept. of Phamc., Jichi Med. Univ., Tochigi, Japan, 9. Adv.Med. Res. Ctr., Fac. of Med, Univ. of the Ryukyus, Okinawa, Japan)
[3P-259] Screening of the CNS-targeted compounds to enhancing mitochondrial calcium uptake for development of novel mood stabilizers
Presentation at Industrial-Academic Collaboration
*Mie Kubota-Sakashita1,2, Hirochika Kawakami1,2, Fumiyuki Shirai2, Ko Kikuzato2, Takemichi Nakamura2, Tadafumi Kato1 (1. Grad Sch of Med, Juntendo University, Tokyo, Japan, 2. RIKEN Center for Sustainable Resource Science, Saitama, Japan)
*Noriyuki Kawamura1, Akinori Nakata2, Tsuyoto Harada1, Yoshiaki Ohashi3, Hajime Sato3, kazunori Sasaki3, Teruhiko Higuchi4 (1. Kawamura Clinic for General Practice, Gyouki-Kai Medical Corporation, Tokyo, Japan, 2. Graduate School of Public Health, International University of Health and Welfare, Tokyo, Japan, 3. Human Metabolome Technologies, Yamagata, Japan, 4. Japan Depression Center, Tokyo, Japan)
*Hiroto Yamauchi1, Shinsuke Matsuzaki 1,2,3,4 (1. Grad Sch Med Sci, Morinomiya Univ of Med Sci, Osaka, Japan, 2. Dept of Radiol Sci, Fac of Med Sci Tech, Morinomiya Univ of Med Sci, Osaka, Japan, 3. MINCL, Morinomiya Univ of Med Sci, Osaka, Japan, 4. Dept of Child Develop & Mol Brain Sci, Unit Grad Sch of Child Develop, Osaka Univ, Osaka, Japan)